1. Home
  2. OCGN vs CTRN Comparison

OCGN vs CTRN Comparison

Compare OCGN & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • CTRN
  • Stock Information
  • Founded
  • OCGN 2013
  • CTRN 1946
  • Country
  • OCGN United States
  • CTRN United States
  • Employees
  • OCGN N/A
  • CTRN N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • CTRN Clothing/Shoe/Accessory Stores
  • Sector
  • OCGN Health Care
  • CTRN Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • CTRN Nasdaq
  • Market Cap
  • OCGN 283.3M
  • CTRN 280.0M
  • IPO Year
  • OCGN N/A
  • CTRN 2005
  • Fundamental
  • Price
  • OCGN $1.05
  • CTRN $31.97
  • Analyst Decision
  • OCGN Strong Buy
  • CTRN Buy
  • Analyst Count
  • OCGN 3
  • CTRN 2
  • Target Price
  • OCGN $6.00
  • CTRN $24.50
  • AVG Volume (30 Days)
  • OCGN 2.6M
  • CTRN 49.4K
  • Earning Date
  • OCGN 08-01-2025
  • CTRN 08-26-2025
  • Dividend Yield
  • OCGN N/A
  • CTRN N/A
  • EPS Growth
  • OCGN N/A
  • CTRN N/A
  • EPS
  • OCGN N/A
  • CTRN N/A
  • Revenue
  • OCGN $4,754,000.00
  • CTRN $768,518,000.00
  • Revenue This Year
  • OCGN N/A
  • CTRN $6.80
  • Revenue Next Year
  • OCGN N/A
  • CTRN $4.61
  • P/E Ratio
  • OCGN N/A
  • CTRN N/A
  • Revenue Growth
  • OCGN N/A
  • CTRN 1.85
  • 52 Week Low
  • OCGN $0.52
  • CTRN $13.66
  • 52 Week High
  • OCGN $1.40
  • CTRN $34.63
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 53.85
  • CTRN 55.99
  • Support Level
  • OCGN $1.01
  • CTRN $30.06
  • Resistance Level
  • OCGN $1.07
  • CTRN $33.49
  • Average True Range (ATR)
  • OCGN 0.05
  • CTRN 1.16
  • MACD
  • OCGN 0.00
  • CTRN 0.25
  • Stochastic Oscillator
  • OCGN 66.48
  • CTRN 69.90

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About CTRN Citi Trends Inc.

Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.

Share on Social Networks: